Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections.
about
Clostridium aldenense sp. nov. and Clostridium citroniae sp. nov. isolated from human clinical infections.Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trialsIn vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strainsIn vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds.Ertapenem: a new carbapenem.Recent developments in carbapenems.New insertion sequence elements in the upstream region of cfiA in imipenem-resistant Bacteroides fragilis strainsErtapenem: review of a new carbapenem.Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice.Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.Lactobacillus species: taxonomic complexity and controversial susceptibilities.Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents.A Critical Review of Analytical Methods for Determination of Ertapenem Sodium.Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections.Ertapenem versus piperacillin/tazobactam for diabetic foot infections in China: a Phase 3, multicentre, randomized, double-blind, active-controlled, non-inferiority trial.Physiological Characteristics and Production of Folic Acid of Lactobacillus plantarum JA71 Isolated from Jeotgal, a Traditional Korean Fermented Seafood.In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates.Antibiotic resistance of lactobacilli isolated from two italian hard cheeses.Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study.General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam.National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000.History of antibiotics: from fluoroquinolones to daptomycin (Part 2).Prevalence of antibiotic resistance in anaerobic bacteria: worrisome developments.
P2860
Q31048060-182ADB87-4C6F-4B48-8919-C591132091CFQ33516983-23505358-77DA-4F84-9867-3DFC2B5FDA1CQ33982797-095FC034-398C-45A2-989A-36D47B307DB6Q34104471-9AB3ABF2-ACA6-401E-9AEE-97A87F148280Q34481516-56AAC7A1-8417-421F-AE7C-8817C76A4425Q34581503-BD60A4CC-E2A8-4BE3-A411-45EC988F8674Q34734963-FC3A6B5B-AA33-4898-A53B-132A82B350C0Q36066200-61C67544-016D-4FC9-A2DB-15B02C17335AQ36719706-E589882B-E927-436B-8FD2-CA9679F6A4B2Q36839703-385BCDD1-095B-4FED-8AF4-EB47369D90C0Q38448312-BB7AA61D-1911-42D9-8E1D-95E20805A357Q38665257-655ADE97-DA05-4DE0-A7B6-4D2A1E756B99Q38726679-FA51DF06-8E51-4A25-A443-2FB4BECBD1D9Q39651410-2D3C2085-E687-42F5-ADD8-64B79A9EE2A8Q40786989-9334E74D-9E4E-4F5D-BBC1-7BD60CF7B7EAQ41115478-AF9DAB87-BDCA-42F7-AB96-48D6490B04D1Q42112586-86385D84-0BCC-4A09-979C-F94EE4985649Q43027714-75D6FFF6-91B0-40BC-89FB-F6267C23D465Q43767713-04BC361D-781D-495D-8504-44EFC3CBDA35Q43996920-48C763FE-6A4A-4A4A-8E45-E90837ED4BE2Q44098411-F0A255B8-1AB1-4BBC-BD70-4233A734085FQ44098413-0F7686FF-A27C-4C53-900B-CAF82D3DDDCCQ48202873-8850AD6D-A9CC-4BFA-9EFE-7DE281169CC5Q53892568-E017C55B-9E53-4620-BEFD-C3624DA97F85
P2860
Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Comparative In vitro activitie ...... an intra-abdominal infections.
@ast
Comparative In vitro activitie ...... an intra-abdominal infections.
@en
type
label
Comparative In vitro activitie ...... an intra-abdominal infections.
@ast
Comparative In vitro activitie ...... an intra-abdominal infections.
@en
prefLabel
Comparative In vitro activitie ...... an intra-abdominal infections.
@ast
Comparative In vitro activitie ...... an intra-abdominal infections.
@en
P2093
P2860
P1476
Comparative In vitro activitie ...... an intra-abdominal infections.
@en
P2093
C Vreni Merriam
D M Citron
E J Goldstein
K L Tyrrell
P2860
P304
P356
10.1128/AAC.44.9.2389-2394.2000
P407
P577
2000-09-01T00:00:00Z